Inhibition of Autophagy Reveals ATR Protein Kinase as a Key Mediator of Cisplatin Sensitivity in Osteosarcoma

Documenti analoghi

• The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre‐clinical study
  di: Kaan Low, et al.
  Pubblicazione: (2024)
• Combined Inhibition of ATR and Ribonucleotide Reductase Induces Synergistic Antineoplastic Activity in Osteosarcoma Cells
  di: Natalie Aderhold, et al.
  Pubblicazione: (2026)
• RETRACTION : MicroRNA ‐320a Inhibits Invasion and Metastasis in Osteosarcoma by Targeting Cytoplasmic Polyadenylation Element‐Binding Protein 1
  Pubblicazione: (2025)
• NAT10 Knockdown Improves Cisplatin Sensitivity in Non‐Small Cell Lung Cancer by Inhibiting the TRIM44/PI3K/AKT Pathway
  di: Qi Sun, et al.
  Pubblicazione: (2025)
• Machine Learning–Driven Integration of Cancer Cell Phenotypes Predicts Cisplatin Sensitivity
  di: Haruki Ujiie, et al.
  Pubblicazione: (2025)